查加斯病的分子标:对广泛利用的标的验证,挑战和化合物
Mariana Laureano de Souza1, Thibault Joseph William Jacques Dit Lapierre2, Gabriel Vitor de Lima Marques3
1Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Expert opinion on therapeutic targets
|September 29, 2023
概括
基于目标的药物发现为查加斯病 (CD) 治疗提供了新的希望. 本次审查强调了有希望的蛋白质标和抑制剂,以开发更安全,更有效的治疗方法来对抗这种被忽视的热带疾病.
科学领域:
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
- 药用化学 医学化学
背景情况:
- 查加斯病 (CD) 带来了重大的社会经济挑战.
- 目前对CD的治疗方法有限,特别是在慢性阶段,并且具有严重的副作用.
- 基于目标的方法对于开发新,安全和有效的CD疗法至关重要.
研究的目的:
- 对查加斯病的基于目标的药物发现策略进行审查.
- 强调最近 (过去五年) 在识别和验证药物点方面的进展.
- 讨论关键验证目标的生物相关性,挑战和抑制剂.
主要方法:
- 文献综述,重点关注查加斯病药物发现中的基于目标的方法.
- 鉴定和分析验证的蛋白质标,包括cruzain,trypanothione减少酶等.
- 对所选目标的生物意义和抑制剂状态的评估.
主要成果:
- 一些关键蛋白质 (cruzain,TR,CPY51,Fe-SOD,蛋白酶体,Cyt b,CPSF3) 已被验证为潜在的药物标.
- 对于这些目标,已经确定了有前途的抑制剂.
- 最近对*Trypanosoma cruzi*和计算化学的基因操纵方面的进展有助于目标验证.
结论:
- 基于目标的策略为查加斯病治疗提供了有希望的线索.
- 在 *Trypanosoma cruzi* 操纵和计算工具方面的进步将加速药物开发.
- 在未来十年,在开发新的CD治疗方面预计将取得重大进展.
关键词:
在CYP51的研究中,查加斯病是查加斯病的一种疾病.分裂和多化特异性因子3的分裂和多化特异性因子3克鲁兹海因 (Cruzaine) 是一个游轮.发现药物的发现.蛋白质酶体蛋白质组是什么基于目标的方法是基于目标的方法.更多相关视频
08:48In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
3.3K
06:13Introducing a Gene Knockout Directly Into the Amastigote Stage of Trypanosoma cruzi Using the CRISPR/Cas9 System
Published on: July 31, 2019
9.1K
相关概念视频
01:26Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
01:26Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K